Vaxfab Enterprises Limited (BOM:542803)
India · Delayed Price · Currency is INR 62.14
+0.14 (0.23%)
At close: Aug 19, 2026
Vaxfab Enterprises Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 26.24 | 2.44 | 3.52 | 41.95 | 0.24 |
Cash & Short-Term Investments | 26.24 | 26.24 | 2.44 | 3.52 | 41.95 | 0.24 |
Cash Growth | 977.78% | 977.78% | -30.80% | -91.61% | 17749.79% | 1707.69% |
Accounts Receivable | - | 1,085 | 211.7 | 39.17 | 40.14 | 8.05 |
Other Receivables | - | - | 0.05 | - | - | - |
Receivables | - | 1,548 | 268.6 | 49.16 | 50.12 | 16.85 |
Inventory | - | 70.76 | 662.73 | 5.22 | 46.88 | 1.55 |
Other Current Assets | - | 36.07 | 122.32 | 34.16 | 4.51 | 0.1 |
Total Current Assets | - | 1,681 | 1,056 | 92.06 | 143.46 | 18.74 |
Property, Plant & Equipment | - | 2.36 | 1.18 | 0.18 | 0.67 | 0.76 |
Long-Term Investments | - | 230.87 | 59.45 | 84.02 | 121.11 | 1.2 |
Goodwill | - | 123.6 | - | - | - | - |
Other Intangible Assets | - | 0 | 0 | 0.01 | - | - |
Long-Term Deferred Tax Assets | - | - | 5.82 | 6.35 | 0 | - |
Other Long-Term Assets | - | -0 | - | - | -0 | 0 |
Total Assets | - | 2,038 | 1,123 | 182.62 | 265.23 | 31.53 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 1,110 | 876.69 | 27.31 | 96.69 | - |
Accrued Expenses | - | - | 0.16 | 0.12 | 0.07 | 0.05 |
Short-Term Debt | - | 442.34 | 77.39 | 0.89 | 3.4 | 0.25 |
Current Income Taxes Payable | - | 3.64 | - | 0.06 | 0.88 | - |
Other Current Liabilities | - | 41.37 | 33.96 | 25.76 | - | - |
Total Current Liabilities | - | 1,597 | 988.21 | 54.14 | 101.05 | 0.3 |
Long-Term Deferred Tax Liabilities | - | 5.61 | - | - | - | 0 |
Total Liabilities | - | 1,603 | 988.21 | 54.14 | 101.05 | 0.3 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 400.94 | 86.6 | 86.6 | 84 | 12 |
Additional Paid-In Capital | - | - | 71.4 | 71.4 | 71.4 | 13.8 |
Retained Earnings | - | - | - | - | 6.18 | 2.84 |
Comprehensive Income & Other | - | 35.82 | -23.68 | -29.52 | - | - |
Total Common Equity | 436.76 | 436.76 | 134.32 | 128.48 | 161.58 | 28.64 |
Minority Interest | - | -1.58 | - | - | - | - |
Shareholders' Equity | 435.18 | 435.18 | 134.32 | 128.48 | 164.18 | 31.24 |
Total Liabilities & Equity | - | 2,038 | 1,123 | 182.62 | 265.23 | 31.53 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 442.34 | 442.34 | 77.39 | 0.89 | 3.4 | 0.25 |
Net Cash (Debt) | -416.09 | -416.09 | -74.96 | 2.63 | 38.54 | -0.01 |
Net Cash Growth | - | - | - | -93.17% | - | - |
Net Cash Per Share | -32.94 | -49.51 | -8.92 | 0.31 | 19.57 | -0.01 |
Filing Date Shares Outstanding | 25.3 | 8.4 | 8.4 | 8.4 | 8.4 | 1.2 |
Total Common Shares Outstanding | 25.3 | 8.4 | 8.4 | 8.4 | 8.4 | 1.2 |
Working Capital | - | 83.95 | 67.88 | 37.92 | 42.4 | 18.45 |
Book Value Per Share | 51.97 | 51.97 | 15.99 | 15.30 | 19.24 | 23.86 |
Tangible Book Value | 313.16 | 313.16 | 134.32 | 128.47 | 161.58 | 28.64 |
Tangible Book Value Per Share | 37.26 | 37.26 | 15.99 | 15.29 | 19.24 | 23.86 |
Machinery | - | - | 2.53 | 1.2 | 1.2 | 1.2 |